AttributesValues
rdf:type
rdfs:seeAlso
Description
  • A series of cationic dinuclear p-cymene ruthenium trithiophenolato complexes of the type [(eta(6)-p-MeC6H4Pr(i))2Ru2(SC6H4-p-X)3](+) have been synthesized from the reaction of [(eta(6)-p-MeC6H4Pr(i) )RuCl2]2 with the corresponding thiol, isolated as the chloride salts, and further studied for their electrochemical properties, cytotoxicity towards human ovarian cancer cells, and catalytic activity for glutathione (GSH) oxidation. Complex 1 was also compared with the benzene and hexamethylbenzene analogues [(eta(6)-C6H6)2Ru2(SC6H5)3](+) (12) and [(eta(6)-C6Me6)2Ru2(SC6H5)3](+) (13). The most active compound [11]Cl was structurally studied by single-crystal X-ray diffraction analysis. The concentrations corresponding to 50 % inhibition of cancer cell growth (IC50 values) in the A2780 and A2780cisR cell lines of these complexes except for 6 were in the submicromolar range, complex 11 showing an IC50 value of 0.03 A mu M in both cell lines. The high in vitro anticancer activity of these complexes may be at least partially due to their catalytic potential for the oxidation of GSH, although there is no clear correlation between the IC50 values and the turnover frequencies at about 50 % conversion. However, the cytotoxicity is tentatively correlated to the physicochemical properties of the compounds determined by the electronic influence of the substituents X (Hammett constants sigma (p)) and the lipophilicity of the thiols p-XC6H4SH (calculated log P parameters).
  • A series of cationic dinuclear p-cymene ruthenium trithiophenolato complexes of the type [(eta(6)-p-MeC6H4Pr(i))2Ru2(SC6H4-p-X)3](+) have been synthesized from the reaction of [(eta(6)-p-MeC6H4Pr(i) )RuCl2]2 with the corresponding thiol, isolated as the chloride salts, and further studied for their electrochemical properties, cytotoxicity towards human ovarian cancer cells, and catalytic activity for glutathione (GSH) oxidation. Complex 1 was also compared with the benzene and hexamethylbenzene analogues [(eta(6)-C6H6)2Ru2(SC6H5)3](+) (12) and [(eta(6)-C6Me6)2Ru2(SC6H5)3](+) (13). The most active compound [11]Cl was structurally studied by single-crystal X-ray diffraction analysis. The concentrations corresponding to 50 % inhibition of cancer cell growth (IC50 values) in the A2780 and A2780cisR cell lines of these complexes except for 6 were in the submicromolar range, complex 11 showing an IC50 value of 0.03 A mu M in both cell lines. The high in vitro anticancer activity of these complexes may be at least partially due to their catalytic potential for the oxidation of GSH, although there is no clear correlation between the IC50 values and the turnover frequencies at about 50 % conversion. However, the cytotoxicity is tentatively correlated to the physicochemical properties of the compounds determined by the electronic influence of the substituents X (Hammett constants sigma (p)) and the lipophilicity of the thiols p-XC6H4SH (calculated log P parameters). (en)
Title
  • Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(eta(6)-p-MeC6H4Pr(i))2Ru2(SC6H4-p-X)3](+): synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential
  • Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(eta(6)-p-MeC6H4Pr(i))2Ru2(SC6H4-p-X)3](+): synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential (en)
skos:prefLabel
  • Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(eta(6)-p-MeC6H4Pr(i))2Ru2(SC6H4-p-X)3](+): synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential
  • Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(eta(6)-p-MeC6H4Pr(i))2Ru2(SC6H4-p-X)3](+): synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential (en)
skos:notation
  • RIV/00216208:11310/12:10126170!RIV13-MSM-11310___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, Z(MSM0021620857)
http://linked.open...iv/cisloPeriodika
  • 6
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 139004
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11310/12:10126170
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • glutathione oxidation; lipophilicity; cytotoxicity; cancer; ruthenium (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • DE - Spolková republika Německo
http://linked.open...ontrolniKodProRIV
  • [1BE4E7701D58]
http://linked.open...i/riv/nazevZdroje
  • Journal of Biological Inorganic Chemistry
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 17
http://linked.open...iv/tvurceVysledku
  • Štěpnička, Petr
  • Baquie, Mathurin
  • Dyson, Paul J.
  • Furrer, Julien
  • Giannini, Federico
  • Ibao, Anne-Flore
  • Suess-Fink, Georg
  • Therrien, Bruno
  • Zava, Olivier
http://linked.open...ain/vavai/riv/wos
  • 000306731100010
http://linked.open...n/vavai/riv/zamer
issn
  • 0949-8257
number of pages
http://bibframe.org/vocab/doi
  • 10.1007/s00775-012-0911-2
http://localhost/t...ganizacniJednotka
  • 11310
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 36 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software